Contrast medium attenuates platelet activation and platelet-leukocyte cross–talk

Summary

The influence of ionic and non-ionic contrast media (CM) on platelet and leukocyte activation and platelet-leukocyte crosstalk was investigated in hirudinized whole blood. The blood was incubated with and without the ionic CM ioxaglate and the nonionic CM iodixanol at 37ºC for 5 min, without or with stirring. Platelet and leukocyte activation and platelet-leukocyte aggregation were measured using whole blood flow cytometry. When blood samples were pre-incubated in the presence of 2%, 5%, and 10% of CM without stirring, both ioxaglate and iodixanol had little effect on unstimulated samples, but dose-independently decreased 1 μM ADP-induced platelet P-selectin expression and fibrinogen binding, and thus platelet-leukocyte aggregate formation. Ioxaglate had little effect on leukocyte CD11b expression, whilst iodixanol slightly enhanced resting and N-formyl-methionyl-leucyl-phenylalanine (fMLP; 0.1 μM)-stimulated leukocyte CD11b expression. Blood samples were also incubated with stirring to investigate the impact of CM (5% of ioxaglate or iodixanol) on platelet-leukocyte cross-talk. Collagen induced marked platelet activation and platelet-leukocyte aggregation, and subsequently elevated leukocyte CD11b expression. The latter was attenuated by ioxaglate and iodixanol, and was accompanied by reduced platelet-leukocyte aggregation. In conclusion, the CM ioxaglate and iodixanol attenuate platelet activation and platelet-leukocyte cross-talk. Inhibitory effects of the contrast agents on this cross-talk are apparently exerted by reducing heterotypic conjugation, and may be beneficial in connection with PCI.

Keywords

Contrast media - platelets - leukocytes - platelet-leukocyte cross-talk

• References

• 1 Chronos NA, Goodall AH, Wilson DJ. et al. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology. Circulation 1993; 88: 2035-44.
• 2 Rudnick MR, Goldfarb S.. Pathogenesis of contrastinduced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med 2003; 4 (Suppl. 05) Suppl S28-33.
• 3 Misumi K. et al. The risk of contrast media-induced ventricular fibrillation is lowin canine coronary arteriography with ioxilan. J Vet Med Sci 2000; 62: 421-6.
• 4 Heptinstall S, White A, Edwards N. et al. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice?. Br J Haematol 1998; 103: 1023-30.
• 5 Markou CP. et al. Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates. Thromb Haemost 2001; 85: 488-93.
• 6 Jones I C, Goodall AH. Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis. Thromb Res 2003; 112: 65-71.
• 7 Jung F. et al. Effect of an ionic compared to a nonionic X-ray contrast agent on platelets and coagulation during diagnostic cardiac catheterisation. Pathophysiol Haemost Thromb 2002; 32: 121-6.
• 8 Robertson HJ. Blood clot formation in angiographic syringes containing nonionic contrast media. Radiology 1987; 162: 621-2.
• 9 Pislaru S, Pislaru C, Szilard M. et al. In vivo effects of contrast media on coronary thrombolysis. J Am Coll Cardiol 1998; 32: 1102-8.
• 10 Laffan M. et al. A comparison between the platelet activating properties of different contrast media used in radiology and MRI. Br J Radiol 1997; 70: 798-804.
• 11 Carr DH, Walker AC, White RG. Effects of radiographic contrast media on leukocyte locomotion. Invest Radiol 1981; 16: 133-40.
• 12 Farrow R, Roobottom CA, Wells IP. et al. Effects of radiographic contrast media on leukocyte phagocytosis. Acad Radiol 1994; 1: 249-52.
• 13 Till G, Rother U, Gemsa D. Activation of complement by radiographic contrast media: generation of chemotactic and anaphylatoxin activities. Int Arch Allergy Appl Immunol 1978; 56: 543-50.
• 14 Feldman LJ, Chollet-Martin S, Himbert D. et al. Modulation of the expression of the granulocyte adhesion molecule, CR3, by percutaneous transluminal coronary angioplasty and contrast media. Invest Radiol 1994; 29: 313-8.
• 15 Vermeiren GL, Willems R, Claeys MJ. et al. Influence of ionic and non-ionic radiographic contrast media on leukocyte adhesionmolecules. Mediators Inflamm 2003; 12: 269-75.
• 16 Bazzoni G, Dejana E, Del Maschio A. Plateletneutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991; 76: 491-9.
• 17 Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-7.
• 18 Li N. et al. Platelet-leukocyte cross talk in whole blood. Arterioscl Thromb Vasc Biol 2000; 20: 2702-8.
• 19 Lee MS. et al. Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation- fibrinolysis system. J Pathol 2004; 203: 861-70.
• 20 Li N. et al. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997; 8: 517-23.
• 21 Li N. et al. Awhole-blood flowcytometric assay for leukocyte CD11b expression using fluorescence signal triggering. Eur J Haematol 2000; 65: 57-65.
• 22 Li N, Goodall AH, Hjemdahl P. Efficient flowcytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 1999; 35: 154-61.
• 23 Albanese JR. et al. Effects of ionic and nonionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol 1995; 76: 1059-63.
• 24 Ogawa T, Fujii S, Urasawa K. et al. Effects of nonionic contrast media on platelet aggregation: assessment by particle counting with laser-light scattering. Jpn Heart J 2001; 42: 115-24.
• 25 Colman RW, Hirsh J, Marder VJ. et al. Plasma factors and inhibitors: procoagulants and fibrinolytic proteins. In: Hemostasis and Thrombosis. Basic Princples and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN. (ed) Philadelphia: Lippincott Willams & Wilkins; 2001: pp 17-20.
• 26 Huo Y. et al. Circulating activated platelets exacerbate atherosclerosis inmice deficient in apolipoprotein E. Nat Med 2003; 9: 61-7.
• 27 Amirkhosravi A. et al. The importance of platelets in the expression of monocyte tissue factor antigen measured by a newwhole blood flowcytometric assay. Thromb Haemost 1996; 75: 87-95.
• 28 Giesen PL, Rauch U, Bohrmann B. et al. Bloodborne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
• 29 Rauch U. et al. Transfer of tissue factor from leukocytes to platelets ismediated by CD15 and tissue factor. Blood 2000; 96: 170-5.
• 30 Laskey WK, Gellman J. Inflammatory markers increase following exposure to radiographic contrast media. Acta Radiol 2003; 44: 498-503.
• 31 Schrader R. Thrombogenic potential of non-ionic contrast media--fact or fiction?. Eur J Radiol 1996; 23 (Suppl. 01) Suppl S10-3.
• 32 Al Dieri R, Beguin S, Hemker HC. The ionic contrast medium ioxaglate interferes with thrombinmediated feedback activation of factor V, factor VIII and platelets. J Thromb Haemost 2003; 1: 269-74.
• 33 Schrader R. et al. Arandomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J Am Coll Cardiol 1999; 33: 395-402.
• 34 Bertrand ME. et al. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) onmajor adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. VIP Trial Investigators. Circulation 2000; 101: 131-6.
• 35 Davidson CJ. et al. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation 2000; 101: 2172-7.
• 36 Scheller B, Hennen B, Pohl A. et al. Acute and subacute stent occlusion; risk-reduction by ionic contrast media. Eur Heart J 2001; 22: 385-91.